Zhonghua Yi Xue Yi Chuan Xue Za Zhi
September 2024
Objective: To explore the Rh genotype for a female with RhD(-) blood type and its molecular basis.
Methods: A 26-year-old female who had attended the outpatient clinic of the First Affiliated Hospital of Zhengzhou University in August 2019 was selected as the study subject. Peripheral blood samples were collected from the proband and her parents for Rh phenotyping with gel card method.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
August 2022
Objective: To investigate the effectiveness and safety of low concentration dithiothreitol (DTT) in removing the interference of monoclonal anti-CD38 on transfusion compatibility testing, and develop a reasonable clinical transfusion strategy.
Methods: The blood type, direct antiglobulin testing (DAT) and antibody screening were tested according to standard methods. Antibody screening cells and donor's red blood cells were treated by DTT 0.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2021
Objective: To detect the ABO / RhD blood type of infants younger than 6 months in different gestational age and month old with automatic microcolumn glass sphere and tube method, and compare the result of the two methods.
Methods: The data of 896 samples of infants younger than 6 months from January 2018 to February 2019 was collected. The two methods were used to detect ABO/RhD blood type in all samples and compare the detection rate of ABO/RhD antigen and ABO reverse typing and agglutination intensity of the two methods.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2020
Objective: To identify the difficult antibody specificity of 1 PNH patient with blood transfusion history by genotyping.
Methods: RH typing of this patient was performed using gel card method, the antibody specificity was identified by panel cells, the RH-unrelated phenotype were excluded by genotyping method in difficult condition of serologic identification, furthmore different RH phenotype cells were used for adsorption-elution so as to re-examine the reactivity of antibodies in this patient's serum, and finally different RH phenotype cells were combined to exclude other unrelated antibodies.
Results: The RH phenotype presented as double population for C antigen, and positive agglutination for the other antigens.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
May 2020
Objective: To explore the molecular basis for an A subtype of the ABO blood group.
Methods: The forward and reverse typing of the ABO blood group were identified by gel card and test tube methods. The ABO gene of the patient was detected by PCR-sequence specific primer (PCR-SSP).
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2017
Objective: To compare the differences between weak ABO antigen patients and normal ABO antigen patients with acute leukemia, and to explore the clinical significance of weak ABO antigen in acute leukemia.
Methods: The ABO blood group was detected in 110 newly diagnosed acute leukemia patients(including 68 cases of AML and 42 cases of ALL) and 68 normal controls. Then the leukemia subtype, age, sex, laboratory test, risk status of leukemia patients, and DNA methylation of ABO promoter were compared between patients with weak and normal ABO antigen.